SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SpectraCure AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7547
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SpectraCure AB (SpectraCure) is a provider of cancer treatment solutions that offers medical device systems containing laser light sources and photoreactive drugs. The company develops and therapy system, commercializes photodynamic with IDOSE for tumors. It provides IDOSE platform which allows tomographic mapping and controls the interstitial PDT treatments, used for accurate dosimetry of internal tumors and to avoid damage to healthy tissue. SpectraCure offers IDOSE which can also perform real-time adjustments to the dose plan covering the different parts of the target tissue. The company’s IDOSE offers treatments through 3D image-based treatment planning using advanced dose-planning tools. It also provides multicentre clinical trials for recurrent prostate cancer. SpectraCure is headquartered in Lund, Sweden.

SpectraCure AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SpectraCure AB, Medical Devices Deals, 2012 to YTD 2018 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SpectraCure AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
Equity Offering 13
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB – Key Competitors 14
SpectraCure AB – Key Employees 15
SpectraCure AB – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Feb 23, 2018: New patient treatment in the clinical phase 1 study 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SpectraCure AB, Pharmaceuticals & Healthcare, Key Facts 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SpectraCure AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SpectraCure AB, Deals By Therapy Area, 2012 to YTD 2018 8
SpectraCure AB, Medical Devices Deals, 2012 to YTD 2018 9
SpectraCure AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SpectraCure Partners with Princess Margaret Hospital 11
SpectraCure Enters into Agreement with Larix 12
SpectraCure Raises USD2.73 Million in IPO of Shares and Warrants 13
SpectraCure AB, Key Competitors 14
SpectraCure AB, Key Employees 15

List of Figures
SpectraCure AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SpectraCure AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SpectraCure AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SpectraCure AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SpectraCure AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析
    Summary Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atop …
  • Qatar Petroleum-石油・ガス分野:企業M&A・提携分析
    Summary Qatar Petroleum (QP) is a state-owned oil and gas company. The company, along with subsidiaries, affiliates and joint ventures, undertake the exploration, drilling, production, storage, transportation, marketing and sale of crude oil, natural gas and gas liquids, liquefied natural gas (LNG), …
  • J.Crew Group, Inc.:企業の戦略・SWOT・財務分析
    J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.Crew Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Response Biomedical Corp:企業の戦略的SWOT分析
    Response Biomedical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • El Gezirah Hotels & Tourism Co. S.A.E.:企業の戦略・SWOT・財務分析
    El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report Summary El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Pt Pioneerindo Gourmet International Tbk:企業の戦略・SWOT・財務分析
    Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Pioneerindo Gourmet International Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • General Motors Co (GM):企業の財務・戦略的SWOT分析
    General Motors Co (GM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mediobanca Private Banking:企業の戦略・SWOT・財務情報
    Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Samyang Biopharmaceuticals Corp-製薬・医療分野:企業M&A・提携分析
    Summary Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, s …
  • AutoZone Inc (AZO):企業の財務・戦略的SWOT分析
    AutoZone Inc (AZO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Alphatec Holdings Inc (ATEC)-医療機器分野:企業M&A・提携分析
    Summary Alphatec Holdings Inc (Alphatec) is a medical technology company that carries out the design, development, manufacturing and marketing of implants for the surgical treatment of spine disorders. Its major products include anterior cervical plate system, posterior cervico/thoracic fixation sys …
  • HDI-Global SE:企業の戦略・SWOT・財務情報
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • American Woodmark Corp (AMWD):企業の財務・戦略的SWOT分析
    American Woodmark Corp (AMWD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Premier Biomedical Inc (BIEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Premier Biomedical Inc (Premier Biomedical) is a drug development company that develops medications for debilitating and fatal illnesses. The company offers Feldetrex, a drug candidate used for the treatment of multiple sclerosis, fibromyalgia, blood sepsis and viremia, and cancer. It develo …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Canada Goose Holdings Inc (GOOS):企業の財務・戦略的SWOT分析
    Canada Goose Holdings Inc (GOOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Vietnam National Oil and Gas Group:石油・ガス:M&Aディール及び事業提携情報
    Summary Vietnam National Oil and Gas Group (Petrovietnam) is an oil and gas exploration and production company. The company conducts petroleum activities and signs petroleum contracts with organizations and individuals. Its services include oil and natural gas exploration and production, petroleum a …
  • Swire Pacific Ltd:企業の戦略・SWOT・財務情報
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nufarm Limited:企業の戦略・SWOT・財務情報
    Nufarm Limited - Strategy, SWOT and Corporate Finance Report Summary Nufarm Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆